Home Biotechnology Rare Thyroid Therapeutics
R

Rare Thyroid Therapeutics

Profile managed by Bizz Id

Egetis Therapeutics

Suecia 1-10 employees

Description

Swedish biopharmaceutical company focused on developing therapies for rare thyroid hormone disorders, including MCT8 deficiency (Allan-Herndon-Dudley Syndrome). Acquired by PledPharma and rebranded as Egetis Therapeutics.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free